Jeff Margolis Examines How Western Companies Can Capitalize on the Opportunities in India

India is emerging as a significant player in the life science sector. The 2005 patent amendments have brought India into the modern world in terms of intellectual property.

Read more »

Vigilant Biosciences Aims to Lower Oral Cancer Mortality with Simple Screening Test

Nearly 40 percent of oral cancer patients will die within five years of diagnosis.

Read more »

February 13-14, 2012 BIO CEO Investor Conference

The BIO CEO & Investor Conference is the largest investor conference focused on established and emerging publicly traded biotech companies. […]

Read more »

Protected: Smart Stocks Watch: Stellar Pharmaceuticals — Migraines, Pain, Urology, Dermatology, Cardiology

There is no excerpt because this is a protected post.

Read more »

James Huang, China Forum II Co-Chair, Investigates the Big Trends in Chinese Healthcare

American firms looking to expand into China face some challenges and Huang dissects strategies to navigate this complex process.

Read more »

Editor’s Note December 20, 2012

With a new year upon us, we are reminded of the year that is now coming to a close.  2011 […]

Read more »

Mirna Therapeutics Uses Synthetic miRNA to Fight Disease

Researchers discovered that miRNA plays an important role in a process known as transcription. .Since its miRNA is a mimic, it has the same sequence as the natural miRNA found in cells.

Read more »

Excelimmune Optimizes the Natural Power of the Immune System

MRSA, which is commonly acquired through contact within the community, is resistant to most first-line antimicrobials on the market.

Read more »

Biovista’s Drug Repositioning Program Creates a Pipeline of New Drugs from Existing Ones

Clinical Outcome Search Space (COSS) uses the Mechanism of Action approach to find additional uses for current medications.

Read more »

This Week in Diagnostics

Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.

Read more »